PER
Click for more information
10.5% 7.4¢ percheron therapeutics limited

Ann: Change of Director's Interest Notice (CG,MD), page-10

  1. mephistophles
    1,067 Posts.
    lightbulb Created with Sketch. 498
    clock Created with Sketch.
    30/04/22
    14:46
    Post #: 61122291
    I'm still not grokking why people are assuming CG & MD are in a window where they're permitted to buy shares on market.

    Wouldn't they have to wait until new patent details are public knowledge?

    Again, I probably missed that update (have been swamped). A quick flick back isn't revealing anything... keen to see the details if someone has them.
    Last edited by mephistophles: 30/04/22
    ANP Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢ 		Change
0.007(10.5%) 		Mkt cap ! $66.71M
Open High Low Value Volume
6.5¢ 7.5¢ 6.3¢ $91.29K 1.309M

Buyers (Bids)

No. Vol. Price($)
1 49999 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 75476 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.